Cargando…

Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine

Systemic sclerosis, also known as scleroderma or SSc, is a condition characterized by significant heterogeneity in clinical presentation, disease progression, and response to treatment. Consequently, the design of clinical trials to successfully identify effective therapeutic interventions poses a m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benfaremo, Devis, Agarbati, Silvia, Mozzicafreddo, Matteo, Paolini, Chiara, Svegliati, Silvia, Moroncini, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454358/ https://www.ncbi.nlm.nih.gov/pubmed/37628728 http://dx.doi.org/10.3390/ijms241612548

Ejemplares similares

PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis
por: Paolini, Chiara, et al.
Publicado: (2022)

Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study
por: Mozzicafreddo, Matteo, et al.
Publicado: (2023)

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches
por: Benfaremo, Devis, et al.
Publicado: (2022)

Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis
por: Agarbati, S., et al.
Publicado: (2022)

Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice
por: Moroncini, Gianluca, et al.
Publicado: (2018)

Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro
por: Svegliati, Silvia, et al.
Publicado: (2017)

Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study
por: Mattioli, Massimo, et al.
Publicado: (2022)

Corrigendum: Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro
por: Svegliati, Silvia, et al.
Publicado: (2017)

New Insights into the Role of Oxidative Stress in Scleroderma Fibrosis
por: Gabrielli, Armando, et al.
Publicado: (2012)

Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations
por: Murdaca, Giuseppe, et al.
Publicado: (2021)

6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study
por: Martino, Giuseppe Pio, et al.
Publicado: (2022)

Toward Molecular Stratification and Precision Medicine in Systemic Sclerosis
por: Noviani, Maria, et al.
Publicado: (2022)

Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?
por: Benfaremo, Devis, et al.
Publicado: (2019)

Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients
por: Danieli, Maria Giovanna, et al.
Publicado: (2022)

Metabolomic profile of systemic sclerosis patients
por: Murgia, Federica, et al.
Publicado: (2018)

SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study
por: Luchetti Gentiloni, Michele Maria, et al.
Publicado: (2022)

Diagnosis and management of leukocytoclastic vasculitis
por: Fraticelli, Paolo, et al.
Publicado: (2021)

Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study
por: Campochiaro, Corrado, et al.
Publicado: (2023)

Isolated Aortitis Presenting with an Annoying Persistent Cough: A Case Report
por: Luchetti, Michele Maria, et al.
Publicado: (2016)

New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review
por: Perrotta, Fabio Massimo, et al.
Publicado: (2021)

Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs
por: Benfaremo, Devis, et al.
Publicado: (2019)

Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement
por: Patrone, Vania, et al.
Publicado: (2017)

Precision medicine in the treatment stratification of AML patients: challenges and progress
por: Lohse, Ines, et al.
Publicado: (2018)

Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature
por: Benfaremo, Devis, et al.
Publicado: (2018)

Junctional Epidermolysis Bullosa: Allelic Heterogeneity and Mutation Stratification for Precision Medicine
por: Condrat, Irina, et al.
Publicado: (2019)

Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care
por: Haselmann, Verena, et al.
Publicado: (2022)

Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy
por: Benfaremo, Devis, et al.
Publicado: (2021)

The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review
por: Bonomi, Francesco, et al.
Publicado: (2022)

Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD
por: Noor, Nurulamin M, et al.
Publicado: (2021)

A young man with persistent dyspepsia: the unexpected virtue of proton-pump inhibitors
por: Paolo, Fraticelli, et al.
Publicado: (2018)

Immune cell profiling in atherosclerosis: role in research and precision medicine
por: Fernandez, Dawn M., et al.
Publicado: (2021)

Amyotrophic lateral sclerosis: the complex path to precision medicine
por: Talbot, Kevin, et al.
Publicado: (2018)

Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
por: Stoessel, Daniel, et al.
Publicado: (2018)

Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification
por: Kansal, Rina
Publicado: (2016)

MediBoost: a Patient Stratification Tool for Interpretable Decision Making in the Era of Precision Medicine
por: Valdes, Gilmer, et al.
Publicado: (2016)

Genetic underpinnings of recovery after stroke: an opportunity for gene discovery, risk stratification, and precision medicine
por: Acosta, Julián N., et al.
Publicado: (2019)

Clinicians’ Perceptions towards Precision Medicine Tools for Cardiovascular Disease Risk Stratification in South Africa
por: Kamp, Michelle, et al.
Publicado: (2022)

Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study
por: Luchetti Gentiloni, Michele Maria, et al.
Publicado: (2023)

Measuring treatment response to advance precision medicine for multiple sclerosis
por: Calabresi, Peter A., et al.
Publicado: (2021)

Enhancing risk stratification for life‐threatening ventricular arrhythmias in dilated cardiomyopathy: the peril and promise of precision medicine
por: Asatryan, Babken, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hq1j9hefbnngillicm2kmi7ss9